Herpes Zoster Ophthalmicus Following Platelet-Rich Plasma Therapy for Androgenetic Alopecia

    September 2025 in “ BMJ Case Reports
    George Riding, Sam Myers, Saurabh Jain
    TLDR Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.
    A man in his 60s developed herpes zoster ophthalmicus (HZO) with secondary preseptal cellulitis after receiving platelet-rich plasma (PRP) injections for androgenetic alopecia. Initially misdiagnosed as an allergic reaction and bacterial cellulitis, his condition worsened until HZO was confirmed and treated with intravenous antivirals and antibiotics. This is the second reported case of HZO following PRP, suggesting a rare potential adverse reaction. The temporal and anatomical association strongly implicates PRP as a trigger, possibly due to immune modulation or contamination. The study emphasizes the importance of standardized PRP protocols and administration by trained medical professionals to mitigate risks.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 106 results

    Related Research

    1 / 1 results